placeholder image

DR Kylie Quinn


  • Adjuvants
  • Ageing
  • HIV
  • Influenza
  • T cell immunity
  • Tuberculosis
  • Vaccination



  • I gained my PhD in the lab of Dr Joanna Kirman, based at the Malaghan Institute in Wellington, New Zealand, where my thesis work was focused on the effect of T regulatory cells on mycobacterial infection and vaccination. I continued to focus on mechanisms of vaccine action when I joined the Vaccine Research Center (VRC) at the National Institutes of Health as a Visiting Fellow in 2008. At the VRC, I worked in the Cellular Immunology Section, headed by Dr Robert Seder, and in the Innate Immunity Consortium for the Collaboration for AIDS Vaccine Discovery (CAVD). CAVD was launched by the Bill and Melinda Gates Foundation in 2006 and aims to accelerate progress toward an AIDS vaccine by promoting shared scientific information and the standardization of laboratory techniques and data analysis. In my work for CAVD, I directly compared several lead HIV vaccine candidates and defined key mechanisms of vaccine action, which will be used to improve HIV vaccine design and selection. After finishing up at the VRC in 2013, I joined the lab of A/Prof Nicole La Gruta at the Peter Doherty Institute (PDI). At the PDI, I am continuing to examine approaches that improve vaccine design, now with a focus on Influenza infection and within elderly populations.   


Member of

  • Australasian Society of Immunology. Full membership 2014 -
  • Australian Society for Medical Research. Full membership 2014 -
  • International Cytokine and Interferon Society. Full membership 2014 -


Selected publications


Education and training

  • PhD, Victoria University 2008
  • BSc(Hons) 1st class, University of Otago 2004


Available for supervision

  • Y